Monitoring for Leukemia Recurrence in a Patient with Infected Eczema
In a patient with prior leukemia in remission who develops infected eczema, you must immediately obtain a complete blood count with differential and peripheral blood smear, and maintain a very low threshold to biopsy any persistent, atypical, or treatment-resistant skin lesions to rule out leukemia cutis, which can herald systemic relapse.
Key Warning Signs to Watch For
Hematologic Parameters
The most critical initial step is laboratory evaluation 1:
- Complete blood count with manual differential - Look specifically for:
- New or worsening cytopenias (anemia, thrombocytopenia, leukopenia)
- Peripheral blood blasts
- Abnormal leukocyte differential
- Peripheral blood smear review - Essential for detecting circulating blasts that may not be apparent on automated counts 1
- Reticulocyte count - Helps distinguish bone marrow failure from other causes of cytopenia 2
Cutaneous Red Flags Requiring Biopsy
Biopsy any skin lesion that exhibits these characteristics 3, 4, 5:
- Fails to respond to appropriate antimicrobial therapy within expected timeframe
- Infiltrated papules, nodules, or plaques - especially if erythematous or violaceous
- Rapidly progressive or spreading lesions despite treatment
- Unusual distribution or morphology inconsistent with typical eczema
- Fungating, ulcerated, or hemorrhagic lesions
- Lesions at sites of prior trauma or procedures (Koebner-like phenomenon) 6
The evidence is clear: leukemia cutis can present as the first and only sign of relapse, even when bone marrow remains in remission 3, 7, 8. Multiple case reports document isolated extramedullary cutaneous relapse occurring years after successful treatment.
Clinical Examination Priorities
Beyond the skin, perform focused assessment for 2:
- Constitutional symptoms: Progressive fatigue, fever, night sweats, unintentional weight loss
- Bleeding manifestations: New petechiae, bruising, epistaxis
- Organomegaly: Splenomegaly, hepatomegaly, lymphadenopathy
- Neurologic symptoms: Headaches, cranial nerve deficits (may indicate CNS involvement)
Surveillance Frequency
If the CBC and skin lesions are concerning, do not wait 2:
- Repeat CBC within 2-4 weeks if abnormal or worsening
- Proceed directly to bone marrow evaluation if peripheral blasts are detected or cytopenias worsen
- For stable patients with normal counts, continue surveillance CBC at minimum annually, though every 3-6 months is reasonable given history 2
When to Escalate to Bone Marrow Evaluation
Obtain bone marrow aspirate and biopsy with full workup (morphology, flow cytometry, cytogenetics, molecular studies) if 1:
- Peripheral blood shows blasts or unexplained cytopenias
- Skin biopsy confirms leukemia cutis
- Progressive or new cytopenias develop
- Clinical suspicion remains high despite negative initial testing
Critical Pitfall to Avoid
The most dangerous error is dismissing persistent or atypical skin lesions as simple infection or dermatitis 5. The literature repeatedly emphasizes that leukemia cutis can mimic benign conditions, including:
- Cellulitis or bacterial infection
- Allergic drug reactions
- Chronic dermatitis
One case report specifically describes a lesion initially thought to be antibiotic-related rash that proved to be leukemia cutis on biopsy 5. Another documents leukemia cutis presenting as "eczema with infection" that was actually isolated extramedullary relapse 8.
Special Considerations for Infected Eczema
The presence of infection complicates assessment because:
- Infection itself can cause reactive changes in blood counts
- Inflammatory skin changes may obscure underlying infiltration
- Immunosuppression from prior leukemia treatment increases infection susceptibility 9
Therefore, if skin lesions persist beyond 7-10 days of appropriate antimicrobial therapy, biopsy is mandatory 4. The biopsy should include immunohistochemistry and flow cytometry if sufficient tissue is obtained 10.
Patient Education
Inform the patient to seek immediate evaluation for 2:
- Progressive fatigue or weakness
- New bleeding or bruising
- Persistent fever
- Any new skin lesions or changes in existing lesions
- Worsening of treated skin lesions
The evidence demonstrates that leukemia cutis in the setting of relapsed disease carries particularly poor prognosis 4, making early detection through vigilant monitoring essential for any chance of successful salvage therapy.